Tissue repair and regeneration after damage is not completely understood, and current
therapies to support this process are limited. The wound healing process is associated with …

Idiopathic pulmonary fibrosis (IPF) is an advancing and fatal lung disease with increasing
incidence and prevalence. Nintedanib and pirfenidone were approved by the FDA for the …

Background High morbidity and mortality rates of the COVID-19 pandemic have made it a
global health priority. Acute respiratory distress syndrome (ARDS) is one of the most …

The immune system is receiving increasing attention for interstitial lung diseases, as
knowledge on its role in fibrosis development and response to therapies is expanding …

Live cell manipulation is an important biotechnological tool for cellular and tissue level
bioengineering applications due to its capacity for guiding cells for separation, isolation …

Exosomes are cell-derived components composed of proteins, lipid, genetic information,
cytokines, and growth factors. They play a vital role in immune modulation, cell-cell …

Idiopathic pulmonary fibrosis (IPF) therapy has always been a big and long-standing
challenge in clinical practice due to the lack of miraculous medicine. Mesenchymal stem …

Idiopathic pulmonary fibrosis (IPF) is characterised by an important remodelling of lung
parenchyma. Current evidence indicates that the disease is triggered by alveolar epithelium …

In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan city, Hubei province,
China. Rapidly escalated into a worldwide pandemic, it has caused an unprecedented and …

Pulmonary fibrosis (PF) is a chronic, progressive, fibrotic interstitial disease of the lung with
poor prognosis and without effective treatment currently. Data from previous coronavirus …